Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase

FEBS Letters

Volumn 583, Issue 17, 2009, Pages 2715-2719

  Jogo, Misako ^a   Shiraishi, Seiji ^a   Tamura, Taka aki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Atrogin 1; MAFbx; Myogenesis; Myogenin; SCF; Ubiquitination

Indexed keywords

ATROGIN 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DEXAMETHASONE; F BOX PROTEIN; MYOGENIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DEXAMETHASONE; GLUCOCORTICOIDS; INSULIN-LIKE GROWTH FACTOR I; MICE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MYOBLASTS; MYOGENIN; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SKP CULLIN F-BOX PROTEIN LIGASES;

EID: 69249222488     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.033     Document Type: Article

References (21)

1. Mitch W.E., and Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335 (1996) 1897-1905
2. Lecker S.H., Solomon V., Mitch W.E., and Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129 (1999) 227S-237S
3. Tawa Jr. N.E., Odessey R., and Goldberg A.L. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100 (1997) 197-203
4. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17 (1998) 7151-7160
5. Skowyra D., Craig K.L., Tyers M., Elledge S.J., and Harper J.W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91 (1997) 209-219
6. Bodine S.C., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
7. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., and Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. USA 98 (2001) 14440-14445
8. Tintignac L.A., Lagirand J., Batonnet S., Sirri V., Leibovitch M.P., and Leibovitch S.A. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J. Biol. Chem. 280 (2005) 2847-2856
9. Sassoon D., Lyons G., Wright W.E., Lin V., Lassar A., Weintraub H., and Buckingham M. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 341 (1989) 303-307
10. Jones N. Transcriptional regulation by dimerization: two sides to an incestuous relationship. Cell 61 (1990) 9-11
11. Shirakata M., Friedman F.K., Wei Q., and Paterson B.M. Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues. Genes Dev. 7 (1993) 2456-2470
12. Shiraishi S., et al. TBP-interacting protein 120B (TIP120B)/cullin-associated and neddylation-dissociated 2 (CAND2) inhibits SCF-dependent ubiquitination of myogenin and accelerates myogenic differentiation. J. Biol. Chem. 282 (2007) 9017-9028
13. Sato S., Chiba T., Sakata E., Kato K., Mizuno Y., Hattori N., and Tanaka K. 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J. 25 (2006) 211-221
14. Adams V., et al. Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc. Res. 73 (2007) 120-129
15. Koyama S., et al. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J. Mol. Biol. 376 (2008) 1224-1236
16. Shiraishi S., Tamamura N., Jogo M., Tanaka Y., and Tamura T. Rapid proteasomal degradation of transcription factor IIB in accordance with F9 cell differentiation. Gene 436 (2009) 115-120
17. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5 (2003) 87-90
18. Petroski M.D., and Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6 (2005) 9-20
19. Centner T., et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J. Mol. Biol. 306 (2001) 717-726
20. Kedar V., McDonough H., Arya R., Li H.H., Rockman H.A., and Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc. Natl. Acad. Sci. USA 101 (2004) 18135-18140
21. Witt S.H., Granzier H., Witt C.C., and Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: Towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 350 (2005) 713-722